Target intelligence / Profile preview

Novel transcript, antisense to CNR1 (ENSG00000298549)

Target
ENSG00000298549
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other (non-protein coding locus)
01

Overview

This gene (ENSG00000298549) encodes a long non-coding RNA transcribed antisense to the CNR1 locus, which codes for Cannabinoid receptor 1. Long non-coding RNAs of this type can potentially regulate neighboring protein-coding genes through various epigenetic and transcriptional mechanisms, but the specific biological role, expression pattern, and clinical significance of this transcript remain poorly characterized with no evidence for direct involvement in disease or response to therapy. It is not classified as a receptor, enzyme, or any other canonical drug target, and is primarily cataloged as an RNA gene in genomic databases. No evidence suggests misspelling, missing information, or incorrect assignment, though the lack of functional and clinical annotation limits its utility in most translational research and therapeutic contexts.

Other names
CNR1 antisense lncRNA
02

Mechanism of action

None established (mechanisms may involve transcriptional interference, RNA-RNA interactions, or chromatin remodeling, but no specific mechanisms documented for this transcript.)

03

Biological functions

Potential regulation of CNR1 expression (inferred from location and antisense nature; direct experimental validation may be lacking)Other (functions of most antisense lncRNAs often relate to transcriptional and post-transcriptional regulation)
04

Disease associations

Other (no direct associations with major diseases have been established in search results. By analogy, lncRNAs can play roles in cancer, neurodegenerative disease, and inflammation, but no evidence links ENSG00000298549 specifically.)

Beyond the preview

Go deeper on Novel transcript, antisense to CNR1 (ENSG00000298549).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to CNR1 (ENSG00000298549).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call